Back to Alerts List

Medrad Intego PET Infusion System Source Administration Sets by Bayer: Corrective Action - Particulates Generated in Vial

[Posted 01/11/2017]

AUDIENCE: Risk Manager, Nuclear Medicine

ISSUE: Bayer has determined all Source Administration Sets used with the Medrad Intego PET Infusion System may produce a particulate matter in the medicine vials. The particulates may be created when the tip of the needle pushes through the rubber top of the vial. If this occurs, the particulate matter could enter into the patient and cause serious adverse health consequences including infection, damage of tissue, and death.

BACKGROUND: The Medrad Intego PET Infusion System controls and delivers medications from a chamber to a patient through a needle inserted into a vein during nuclear medicine procedures. Nuclear medicine procedures are used to diagnose and treat diseases such as cancer, thyroid disease, and heart disease. The product was distributed between October 9, 2008 to October 11, 2016 and the recall was initiated November 7, 2016.

RECOMMENDATION: Immediately discontinue the use and quarantine any unused affected product and do one of the following:

  • Retain the quarantined Source Administration Sets to be used when the new qualified in-line filter is received. OR
  • Quarantine Source Administration Sets stock and contact Bayer Customer Care at 1-800-633-7231 opt. 2 to receive a Returned Goods Authorization number and return the product to Bayer accordingly.

Healthcare professionals and patients are encouraged to report adverse events or side effects related to the use of these products to the FDA's MedWatch Safety Information and Adverse Event Reporting Program:

  • Complete and submit the report Online:
  • Download form or call 1-800-332-1088 to request a reporting form, then complete and return to the address on the pre-addressed form, or submit by fax to 1-800-FDA-0178.

[11/07/2016 - Customer Notification Letter - Bayer]



Related Safety Alerts